1.A study on surface of various abutment screws.
Chan Ik PARK ; Chae Heon CHUNG ; Han Cheol CHOI ; Dae Hwa BACK
The Journal of Korean Academy of Prosthodontics 2003;41(3):351-359
STATEMENT OF PROBLEM: Regardless of any restoration, most of case, we used in screw connection between abutment and implant. For this reason, implant screw loosening has been remained problem in restorative practices. PURPOSE: The purpose of this study was to compare surface of coated/plated screw with titanium and gold alloy screw and to evaluate physical property of coated/plated material after scratch test in FESEM investigation. MATERIAL AND METHODS: GoldTite, titanium screw provided by 3i (Implant Innovation, USA) and TorqTite, titanium screw by Steri-Oss (Nobel Biocare, USA) and gold screw, titanium screw by AVANA (Osstem Implant, korea) - were selected for this study. Each abutment screw surface was observed at 100 times, and then screw crest, root, and slope were done more detailed numerical value, at 1000 times with FESEM. A micro-diamond needle was also prepared for the scratch test. Each abutment screw was fixed, micro-diamond scratch the surface of head region was made at constant load and then was observed central region and periphery of fine trace through 1000 times with FESEM. RESULTS: The surface of GoldTite was smoother than that of other kinds of screw and had abundant ductility and malleability compared with titanium and gold screw. The scratch test also showed that teflon particles were exfoliated easily in screw coated with teflon. Titanium screw had a rough surface and low ductility. CONCLUSION: It was recommended that the clinical use of gold-plated screw would prevent a screw from loosening.
Alloys
;
Head
;
Needles
;
Polytetrafluoroethylene
;
Titanium
2.Papaverine Angioplasty for Cerebral Vasospasm: Preliminary Report.
O Ki KWON ; Dong Yeob LEE ; Chang Wan OH ; Moon Hee HAN ; Chae Yong KIM ; Dae Hee HAN
Journal of Korean Neurosurgical Society 2002;32(2):89-95
OBJECTIVE: We present an evaluation of the clinical outcome and an investigation of the optimal use of papaverine angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage. METHODS: The authors retrospectively analyzed 24 cases of symptomatic vasospasm treated by papaverine angioplasty from July 1994 to February 1998. Detailed clinical features and detailed techniques of papaverine angioplasty including sex, age, symptoms, time interval from symptom onset to angioplasty, papaverine dose, concentration and duration of infusion were investigated. RESULTS: After papaverine angioplasty, immediate angiographic vasodilatation was achieved in 23 cases (96%). Fifty eight percent showed clinical improvement within 24 hours but symptomatic vasospasm recurred in 21% of them. Retreatment with papaverine for the recurred cases showed a less response than the initial treatment. Statistical analyses showed that time interval from symptom onset to angioplasty was the factor related to the effects of papaverine angioplasty. CONCLUSION: Our study shows that optimal timing of papaverine angioplasty is very important for clinical improvement.
Angioplasty*
;
Papaverine*
;
Retreatment
;
Retrospective Studies
;
Subarachnoid Hemorrhage
;
Vasodilation
;
Vasospasm, Intracranial*
3.Liver disease in KOrea HBsAg carriers with end stage renal disease.
Chan Shin PARK ; Chae Yoon CHON ; Ki Yong KIM ; Heung Soo KIM ; Kwang Hyub HAN ; Kyu Hun CHOI ; Ho Yung LEE ; Chan Il PARK ; Dae Suk HAN
Korean Journal of Nephrology 1993;12(2):136-143
No abstract available.
Hepatitis B Surface Antigens*
;
Kidney Failure, Chronic*
;
Korea*
;
Liver Diseases*
;
Liver*
4.Carotid Endarterectomy for Carotid Stenosis: Experience of 19 Cases.
Chae Yong KIM ; Chang Wan OH ; Young Seob CHUNG ; O Ki KWON ; Dae Hee HAN
Journal of Korean Neurosurgical Society 2001;30(3):284-294
OBJECTIVES: Stroke is leading cause of death and more importantly it is cause of serious disability. The effective treatment of acute ischemic stroke still remains a challenge to modern medicine. Recent clinical trials have shown that carotid endareterctomy(CEA) provide overwhelming benefits compared with medical therapy in preventing subsequent stroke for symptomatic carotid stenosis. For the asymptomatic ones, the data are less compelling, but highly suggestive that CEA do have benefits in properly selected patients. MATERIALS AND METHODS: To investigate the clinical manifestations of carotid stenosis and results of CEAs, authors analyzed retrospectively 19 CEAs in 16 patients from June 1986 to June 1999. Age of patients ranged from 55 to 76 years(median, 66) and male to female ratio was 14 to 2. The duration of follow-up was 1 to 144 months (median, 26). All of CEAs were done on the side of stenosis more than 80% and bilateral CEAs were done in three. Six CEAs were performed in asymptomatic patients. RESULTS: Seventeen of 19 CEAs showed excellent results and complication rate was low although ipsilateral ischemic stroke occurred in two. CONCLUSION: CEA may be a valuable surgical treatment for ischemic stroke caused by carotid stenosis and also for prevention of stroke of asymptomatic patients with carotid stenosis.
Carotid Stenosis*
;
Cause of Death
;
Constriction, Pathologic
;
Endarterectomy, Carotid*
;
Female
;
Follow-Up Studies
;
History, Modern 1601-
;
Humans
;
Male
;
Retrospective Studies
;
Stroke
5.A Case of Malignant Lymphoma in Patient with Ulcerative Colitis.
Dae Sig KIM ; Han Seul LEE ; Ji Ho YOON ; Dong Chae LEE ; Sung Hyun LEE ; Ji Woon KIM
Korean Journal of Gastrointestinal Endoscopy 2001;23(3):188-191
Ulcerative colitis has been recognized as a premalignant condition because a considerable proportion of patients with colitis eventually develop colorectal carcinoma at the site of the inflammatory disease. Malignant lymphoma occurring in cases of long-standing ulcerative colitis is rare. Cancer risk is positively correlated with duration and anatomic extent of colitis, but do not appear to be increased by early age at onset of disease. Patients with chronic ulcerative colitis should have periodic rectal and colonoscopic biopsies, and those with moderate to marked dysplasia require colectomy because of the increased risk of colon carcinoma. We report a case of malignant lymphoma in patient with ulcerative colitis.
Biopsy
;
Colectomy
;
Colitis
;
Colitis, Ulcerative*
;
Colon
;
Colorectal Neoplasms
;
Humans
;
Lymphoma*
;
Ulcer*
6.Spinal Anesthesia with 0.25 % Hyperbaric Bupivacaine : Effect of Different Dosage .
Dae Young KIM ; Chong Han CHAE ; Nam Soo CHO ; Chong Dal CHUNG ; Yong Il KIM
Korean Journal of Anesthesiology 1991;24(4):737-744
Authors selected 54 patients in ASA class I, II, aged from 20 to 60 years old undergoiag operations of lower limbs and lower abdomen. In the different dosage of 0.25% hyperbaric bupivacaine, these were divided into 3 groups ; group A(22 patients) using l0 mg(4 ml), group B(17 patients) using 15 mg(6 ml), group C(15 patients) using 20 mg(8ml), which were injected into subarachnoid space. The following results were obtained. I) Maimum level of sensory loss was significantly increased with increase dosage, and the time of onset was significantly faster with decrease dosage. 2) Duratioan of sensory loss was significantly longer with increase dosage. 3) Onset time of motor block was signficantly faster in the group C of Bromages scale degree l, Duration of motor block was signficantly longer with increase dosage. 4) Systolic and diastolic blood pressure were little decreased with increase dosage. No signficant changes were noted in the pulse rate. 5) Post spinal headache developed in 5 patients out of 54 patients(9.3%). In the study of the group C, urinary retention developed in 4 patients out of 15 patients. From above results, we conclude that 0.25% hyperbaric bupivacaine can be used for operations lasting than 1~2 hours of lower limbs and lower abdomen because cardiovascular system is little affected with increase dosage.
Abdomen
;
Anesthesia, Spinal*
;
Blood Pressure
;
Bupivacaine*
;
Cardiovascular System
;
Headache
;
Heart Rate
;
Humans
;
Lower Extremity
;
Middle Aged
;
Subarachnoid Space
;
Urinary Retention
7.Urinary Metabolites and Neurobehavioral Test on Styrene Exposure Workers.
Chang Hee LEE ; Deog Hwan MOON ; Hun LEE ; Jun Han PARK ; Dae Hwan KIM ; Jong Tae LEE ; Jin Ho CHUN ; Hwi Dong KIM ; Chae Un LEE
Korean Journal of Preventive Medicine 1996;29(4):863-876
In order to prepare the fundamental data for the health promotion by assessing the exposure level of styrene, the author determined the concentration of mandelic acid and phenylglyoxylic acid in urine of 42 workers who were exposed to styrene by high performance liquid chromatography and surveyed 16 symptoms, by questionnaire and also tested neurobehavioral test(digit symbol, benton visual retention) in 2 FRP plants of Kyung Nam area from July to September, 1995. Control was sampled by age sex matching method. The concentration of styrene in air was determined by gas chromatography. The results were as follows; 1. Geometric mean concentration of styrene in air was 17.4ppm, geometric mean concentration of mandelic acid(MA) in urine were 404.3mg/g creatinine for exposure group, 46.4mg/g creatinine for control group, geometric mean concentration of phenylglyoxylic acid(PGA) in urine were 57.5mg/g creatinine for exposure group, 9.5mg/g creatinine for control group. Mean concentration of MA and PGA showed statistically significant difference between exposure group and control group(p<0.01). 2. Number of symptom were 2.9 for exposure group, 3.3 for control group, number of digit symbol were 24.1 for exposure group, 32.5 for control group, number of Benton visual retention test were 6.1 for exposure group, 6.0 for control group, respectively. As result of adjusting the education year, number of Benton visual retention test showed statistically significant difference between exposure group and control group(p<0.05). 3. Excellent correlation were observed between environmental styrene exposure and urinary MA(r=0.80), PGA(r=0.73), and MA+PGA(r=0.81).
Chromatography, Gas
;
Chromatography, Liquid
;
Creatinine
;
Education
;
Health Promotion
;
Surveys and Questionnaires
;
Styrene*
8.Giant Pituitary Adenoma: Long-Term Outcome after Surgical Treatment of 61 Cases.
Chi Heon KIM ; Chae Yong KIM ; Dong Gyu KIM ; Dae Hee HAN ; Je G CHI ; Hee Won JUNG
Journal of Korean Neurosurgical Society 2003;34(2):91-95
OBJECTIVE: The authors perform a retrospective analysis in order to evaluate long-term outcome results after surgical treatment of giant pituitary adenoma (PA) and to suggest the optimal treatment strategies. METHODS: From 1990 to 2001, we experienced 61 cases of giant PA, the mean size was 4.8cm. The mean follow-up period was 47 months. There were 30 cases of functioning PA and 43 of invasive adenomas. Transsphenoidal approach (TSA) was performed in 47 patients, craniotomy in 6, and a staged operation (TSA followed by craniotomy) in 8. Gross total/near total removal (over 95% removal) was performed in 9 patients (TSA in 8 and craniotomy in one) and subtotal removal (over 50% and less than 95%) in the others. Post-operative radiotherapy (RTx) was performed in thirty-six patients. Treatment results were classified as controlled and non-controlled group. Controlled group was defined as patients with no evidence of mass growth, improvement of mass effect, and endocrinological normalization. RESULTS: Tumor control was possible in 58% and mass control only was observed in 91%. Additive radiotherapy showed a significant benefit on tumor control (p=0.013) in the subtotal removal group. In patients with functioning PA, endocrinological improvement (normalization 32%) was shown in 92% (Radiotherapy, 20 cases). CONCLUSION: Total removal of giant PAs through TSA or craniotomy is not always feasible and often risky. Subtotal resection of giant PAs by TSA with or without subsequent RTx may provide a good local tumor control.
Adenoma
;
Craniotomy
;
Follow-Up Studies
;
Humans
;
Pituitary Neoplasms*
;
Radiotherapy
;
Retrospective Studies
9.Surgical Treatment of Tuberculous Cold Abscess of the Chest Wall.
Hyo Chae PAIK ; Kyung Young CHUNG ; Jeong Han KANG ; Dae Hyeon MAENG
Yonsei Medical Journal 2002;43(3):309-314
The incidence of tuberculosis (Tbc) infection is high in some parts of the world and tuberculous cold abscess of the chest wall (CACW) often fails to respond to medical treatment. Medical records of 178 patients who underwent surgical treatment of chest wall abscesses from July 1970 to Sept. 2000 were reviewed and 89 patients who were pathologically confirmed as Tbc cold abscess cases were included in this study. Their ages ranged from 9 to 71 years (mean 33.3 years) and the male to female ratio was 1.2:1 (49 male, 40 female). The symptoms were palpable chest wall mass, pain and pus discharge, and three patients had multiple lesions. Twenty-five patients (28%) underwent excision of chest wall abscesses and 64 patients (72%) underwent chest wall and rib resection. Tbc medication was given preoperatively in 39 patients for an average of 6.3 months and all patients were given Tbc medication postoperatively for an average of 12 months. Postoperative complications were bleeding, pus discharge, empyema, pleural effusion, wound dehiscence, subcutaneous emphysema and activation of pulmonary Tbc. The disease recurred in 7 patients (7.8%) and these 7 patients all underwent a second operation. We recommend preoperative Tbc medication and complete resection of chest wall abscesses including any suspicious ribs. Postoperative Tbc medication for a minimum of 12 months is essential to decrease the risk of a relapse.
Abscess/drug therapy/*surgery
;
Adolescent
;
Adult
;
Aged
;
Antitubercular Agents/therapeutic use
;
Child
;
Female
;
Human
;
Male
;
Middle Age
;
Retrospective Studies
;
Thoracic Diseases/drug therapy/*surgery
;
*Thoracic Surgical Procedures
;
Thoracic Vertebrae/surgery
;
Tuberculosis/drug therapy/*surgery
10.Hematopoietic Stem Cell Registry Report: 2018
Eun-Suk KANG ; Chae Seung LIM ; Kyou Sup HAN ; Dae-Won KIM
Korean Journal of Blood Transfusion 2020;31(2):109-118
Background:
Hematopoietic stem cell (HSC) transplantation is an important therapeutic option for many malignant and non-malignant diseases. The whole transplant process involves multiple areas and complex steps. The laboratory procedures include the collection, processing, and storage of HSC. The HSC registry aims to identify the current situation and draw improvement points by voluntarily registering the information of an HSC graft collected by each institute sharing the analyzed data. This study analyzed and shared the data for 2018.
Methods:
Data for 2018 registered at the HSC registry website (www.ksfa-registry.org) was downloaded and analyzed. The data were to enter the information of each collection and include the demography of the donors, transplant type, instrument, vascular access, mobilization modality, and the number of CD34+ cells.
Results:
Two thousand eight hundred eighty-eight collection datasets from 1,373 donors were registered from 19 institutes, which was slightly higher than that reported in 2017. The number of collections in one patient was in the range of 1∼17 times, and the average was two times. In allogeneic HSCT, the number of related donors was higher than that of unrelated donors. The frequency of collecting more than four times per donor was 25.2% for autologous donors, compared to 95.4% for allogeneic donors less than twice.
Conclusion
The HSC registry is not limited to identifying the current situation and sharing the analyzed data, but is expected to contribute to the development of guidelines, education of human resources, and the standardization of laboratory procedures involved in hematopoietic stem cell transplantation.